DDB1
DDB1[edit]
DDB1 (Damage-specific DNA binding protein 1) is a protein that plays a crucial role in the cellular response to DNA damage and is involved in various cellular processes, including DNA repair, cell cycle regulation, and transcription. It is a component of the CUL4-DDB1 E3 ubiquitin ligase complex, which is essential for the ubiquitination and subsequent proteasomal degradation of target proteins.
Structure[edit]
DDB1 is a large protein composed of multiple domains that facilitate its interaction with other proteins. It contains a WD40 repeat domain, which is involved in protein-protein interactions, allowing DDB1 to serve as a scaffold for the assembly of various protein complexes.
Function[edit]
DDB1 is primarily known for its role in the nucleotide excision repair (NER) pathway, a mechanism that repairs bulky DNA lesions such as those caused by ultraviolet (UV) radiation. In the context of NER, DDB1 forms a complex with DDB2, another protein that recognizes UV-induced DNA damage. This DDB1-DDB2 complex is crucial for the initial steps of damage recognition and repair.
In addition to its role in DNA repair, DDB1 is a key component of the CUL4-DDB1 E3 ubiquitin ligase complex. This complex targets various proteins for ubiquitination, a process that marks them for degradation by the proteasome. Through this mechanism, DDB1 is involved in regulating the cell cycle, DNA replication, and transcription.
Clinical Significance[edit]
Mutations or dysregulation of DDB1 can lead to impaired DNA repair and genomic instability, contributing to the development of cancer. DDB1 has been implicated in several types of cancer, including skin cancer, due to its role in repairing UV-induced DNA damage.
Furthermore, DDB1 is involved in the regulation of several viral proteins, making it a potential target for antiviral therapies. For example, DDB1 interacts with the Hepatitis B virus X protein, which is essential for viral replication.
Research and Therapeutic Potential[edit]
Given its central role in DNA repair and protein regulation, DDB1 is a target of interest in cancer research. Inhibitors of the CUL4-DDB1 complex are being explored as potential therapeutic agents to sensitize cancer cells to DNA-damaging agents.
See Also[edit]
References[edit]
External Links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian